Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype

Increased susceptibility to fatigue is a negative predictor of survival commonly experienced by women with breast cancer (BC). Here, we sought to identify molecular changes induced in human skeletal muscle by BC regardless of treatment history or tumor molecular subtype using RNA-sequencing (RNA-seq...

Full description

Saved in:
Bibliographic Details
Published in:NPJ breast cancer 2020, Vol.6 (1), p.18-18, Article 18
Main Authors: Wilson, Hannah E, Stanton, David A, Montgomery, Cortney, Infante, Aniello M, Taylor, Matthew, Hazard-Jenkins, Hannah, Pugacheva, Elena N, Pistilli, Emidio E
Format: Article
Language:English
Subjects:
Breast cancer
Gene expression
Musculoskeletal system
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883
cites cdi_FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883
container_end_page 18
container_issue 1
container_start_page 18
container_title NPJ breast cancer
container_volume 6
creator Wilson, Hannah E
Stanton, David A
Montgomery, Cortney
Infante, Aniello M
Taylor, Matthew
Hazard-Jenkins, Hannah
Pugacheva, Elena N
Pistilli, Emidio E
description Increased susceptibility to fatigue is a negative predictor of survival commonly experienced by women with breast cancer (BC). Here, we sought to identify molecular changes induced in human skeletal muscle by BC regardless of treatment history or tumor molecular subtype using RNA-sequencing (RNA-seq) and proteomic analyses. Mitochondrial dysfunction was apparent across all molecular subtypes, with the greatest degree of transcriptomic changes occurring in women with HER2/neu-overexpressing tumors, though muscle from patients of all subtypes exhibited similar pathway-level dysregulation. Interestingly, we found no relationship between anticancer treatments and muscle gene expression, suggesting that fatigue is a product of BC per se rather than clinical history. In vitro and in vivo experimentation confirmed the ability of BC cells to alter mitochondrial function and ATP content in muscle. These data suggest that interventions supporting muscle in the presence of BC-induced mitochondrial dysfunction may alleviate fatigue and improve the lives of women with BC.
doi_str_mv 10.1038/s41523-020-0162-2
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7272425</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2414735001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883</originalsourceid><addsrcrecordid>eNp9UU1rGzEUFKWhCYl_QC5F0Esvm-pbu5dCCfkoBHpIchZa7bO9qbRyJW3A_z4yToLbQw96Esy8YUaD0DklF5Tw9lsWVDLeEEYaQhVr2Ad0wrgWjVBafzx4H6NFzk-EECpU20n6CR1zJiVhip-g8f43eCjW4zBn5wEn2KS4SjaEcVrhfov7BDYX7OzkIFV4ZdPgIWccl7hUrASYCl6PucS0xTHhMoc6Q_TgZm8TznNfths4Q0dL6zMsXu9T9Hh99XB529z9uvl5-eOucULK0nTgloJTTZRkYrAahOwtONrxGoUOwIlrgfNhaIWyshNa2q4eIYRS0rUtP0Xf97qbuQ8wuOouWW82aQw2bU20o_kbmca1WcVno5lmgskq8PVVIMU_M-RiwpgdeG8niHM2TFChuaz_Walf_qE-xTlNNV5lVS-Sqpb9n0U6RVrJd77pnuVSzDnB8t0yJWbXuNk3bmrjZte42Sl_Psz6vvHWL38BaXinUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2409608538</pqid></control><display><type>article</type><title>Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Wilson, Hannah E ; Stanton, David A ; Montgomery, Cortney ; Infante, Aniello M ; Taylor, Matthew ; Hazard-Jenkins, Hannah ; Pugacheva, Elena N ; Pistilli, Emidio E</creator><creatorcontrib>Wilson, Hannah E ; Stanton, David A ; Montgomery, Cortney ; Infante, Aniello M ; Taylor, Matthew ; Hazard-Jenkins, Hannah ; Pugacheva, Elena N ; Pistilli, Emidio E</creatorcontrib><description>Increased susceptibility to fatigue is a negative predictor of survival commonly experienced by women with breast cancer (BC). Here, we sought to identify molecular changes induced in human skeletal muscle by BC regardless of treatment history or tumor molecular subtype using RNA-sequencing (RNA-seq) and proteomic analyses. Mitochondrial dysfunction was apparent across all molecular subtypes, with the greatest degree of transcriptomic changes occurring in women with HER2/neu-overexpressing tumors, though muscle from patients of all subtypes exhibited similar pathway-level dysregulation. Interestingly, we found no relationship between anticancer treatments and muscle gene expression, suggesting that fatigue is a product of BC per se rather than clinical history. In vitro and in vivo experimentation confirmed the ability of BC cells to alter mitochondrial function and ATP content in muscle. These data suggest that interventions supporting muscle in the presence of BC-induced mitochondrial dysfunction may alleviate fatigue and improve the lives of women with BC.</description><identifier>ISSN: 2374-4677</identifier><identifier>EISSN: 2374-4677</identifier><identifier>DOI: 10.1038/s41523-020-0162-2</identifier><identifier>PMID: 32550263</identifier><language>eng</language><publisher>United States: Nature Publishing Group</publisher><subject>Breast cancer ; Gene expression ; Musculoskeletal system</subject><ispartof>NPJ breast cancer, 2020, Vol.6 (1), p.18-18, Article 18</ispartof><rights>The Author(s) 2020.</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883</citedby><cites>FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883</cites><orcidid>0000-0003-0035-4661</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2488351682/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2488351682?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,4043,25783,27956,27957,27958,37047,37048,44625,53827,53829,75483</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32550263$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilson, Hannah E</creatorcontrib><creatorcontrib>Stanton, David A</creatorcontrib><creatorcontrib>Montgomery, Cortney</creatorcontrib><creatorcontrib>Infante, Aniello M</creatorcontrib><creatorcontrib>Taylor, Matthew</creatorcontrib><creatorcontrib>Hazard-Jenkins, Hannah</creatorcontrib><creatorcontrib>Pugacheva, Elena N</creatorcontrib><creatorcontrib>Pistilli, Emidio E</creatorcontrib><title>Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype</title><title>NPJ breast cancer</title><addtitle>NPJ Breast Cancer</addtitle><description>Increased susceptibility to fatigue is a negative predictor of survival commonly experienced by women with breast cancer (BC). Here, we sought to identify molecular changes induced in human skeletal muscle by BC regardless of treatment history or tumor molecular subtype using RNA-sequencing (RNA-seq) and proteomic analyses. Mitochondrial dysfunction was apparent across all molecular subtypes, with the greatest degree of transcriptomic changes occurring in women with HER2/neu-overexpressing tumors, though muscle from patients of all subtypes exhibited similar pathway-level dysregulation. Interestingly, we found no relationship between anticancer treatments and muscle gene expression, suggesting that fatigue is a product of BC per se rather than clinical history. In vitro and in vivo experimentation confirmed the ability of BC cells to alter mitochondrial function and ATP content in muscle. These data suggest that interventions supporting muscle in the presence of BC-induced mitochondrial dysfunction may alleviate fatigue and improve the lives of women with BC.</description><subject>Breast cancer</subject><subject>Gene expression</subject><subject>Musculoskeletal system</subject><issn>2374-4677</issn><issn>2374-4677</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9UU1rGzEUFKWhCYl_QC5F0Esvm-pbu5dCCfkoBHpIchZa7bO9qbRyJW3A_z4yToLbQw96Esy8YUaD0DklF5Tw9lsWVDLeEEYaQhVr2Ad0wrgWjVBafzx4H6NFzk-EECpU20n6CR1zJiVhip-g8f43eCjW4zBn5wEn2KS4SjaEcVrhfov7BDYX7OzkIFV4ZdPgIWccl7hUrASYCl6PucS0xTHhMoc6Q_TgZm8TznNfths4Q0dL6zMsXu9T9Hh99XB529z9uvl5-eOucULK0nTgloJTTZRkYrAahOwtONrxGoUOwIlrgfNhaIWyshNa2q4eIYRS0rUtP0Xf97qbuQ8wuOouWW82aQw2bU20o_kbmca1WcVno5lmgskq8PVVIMU_M-RiwpgdeG8niHM2TFChuaz_Walf_qE-xTlNNV5lVS-Sqpb9n0U6RVrJd77pnuVSzDnB8t0yJWbXuNk3bmrjZte42Sl_Psz6vvHWL38BaXinUQ</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Wilson, Hannah E</creator><creator>Stanton, David A</creator><creator>Montgomery, Cortney</creator><creator>Infante, Aniello M</creator><creator>Taylor, Matthew</creator><creator>Hazard-Jenkins, Hannah</creator><creator>Pugacheva, Elena N</creator><creator>Pistilli, Emidio E</creator><general>Nature Publishing Group</general><general>Nature Publishing Group UK</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0035-4661</orcidid></search><sort><creationdate>2020</creationdate><title>Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype</title><author>Wilson, Hannah E ; Stanton, David A ; Montgomery, Cortney ; Infante, Aniello M ; Taylor, Matthew ; Hazard-Jenkins, Hannah ; Pugacheva, Elena N ; Pistilli, Emidio E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Breast cancer</topic><topic>Gene expression</topic><topic>Musculoskeletal system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilson, Hannah E</creatorcontrib><creatorcontrib>Stanton, David A</creatorcontrib><creatorcontrib>Montgomery, Cortney</creatorcontrib><creatorcontrib>Infante, Aniello M</creatorcontrib><creatorcontrib>Taylor, Matthew</creatorcontrib><creatorcontrib>Hazard-Jenkins, Hannah</creatorcontrib><creatorcontrib>Pugacheva, Elena N</creatorcontrib><creatorcontrib>Pistilli, Emidio E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>NPJ breast cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilson, Hannah E</au><au>Stanton, David A</au><au>Montgomery, Cortney</au><au>Infante, Aniello M</au><au>Taylor, Matthew</au><au>Hazard-Jenkins, Hannah</au><au>Pugacheva, Elena N</au><au>Pistilli, Emidio E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype</atitle><jtitle>NPJ breast cancer</jtitle><addtitle>NPJ Breast Cancer</addtitle><date>2020</date><risdate>2020</risdate><volume>6</volume><issue>1</issue><spage>18</spage><epage>18</epage><pages>18-18</pages><artnum>18</artnum><issn>2374-4677</issn><eissn>2374-4677</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Increased susceptibility to fatigue is a negative predictor of survival commonly experienced by women with breast cancer (BC). Here, we sought to identify molecular changes induced in human skeletal muscle by BC regardless of treatment history or tumor molecular subtype using RNA-sequencing (RNA-seq) and proteomic analyses. Mitochondrial dysfunction was apparent across all molecular subtypes, with the greatest degree of transcriptomic changes occurring in women with HER2/neu-overexpressing tumors, though muscle from patients of all subtypes exhibited similar pathway-level dysregulation. Interestingly, we found no relationship between anticancer treatments and muscle gene expression, suggesting that fatigue is a product of BC per se rather than clinical history. In vitro and in vivo experimentation confirmed the ability of BC cells to alter mitochondrial function and ATP content in muscle. These data suggest that interventions supporting muscle in the presence of BC-induced mitochondrial dysfunction may alleviate fatigue and improve the lives of women with BC.</abstract><cop>United States</cop><pub>Nature Publishing Group</pub><pmid>32550263</pmid><doi>10.1038/s41523-020-0162-2</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0035-4661</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2374-4677
ispartof NPJ breast cancer, 2020, Vol.6 (1), p.18-18, Article 18
issn 2374-4677
2374-4677
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7272425
source Publicly Available Content Database; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects Breast cancer
Gene expression
Musculoskeletal system
title Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T17%3A22%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skeletal%20muscle%20reprogramming%20by%20breast%20cancer%20regardless%20of%20treatment%20history%20or%20tumor%20molecular%20subtype&rft.jtitle=NPJ%20breast%20cancer&rft.au=Wilson,%20Hannah%20E&rft.date=2020&rft.volume=6&rft.issue=1&rft.spage=18&rft.epage=18&rft.pages=18-18&rft.artnum=18&rft.issn=2374-4677&rft.eissn=2374-4677&rft_id=info:doi/10.1038/s41523-020-0162-2&rft_dat=%3Cproquest_pubme%3E2414735001%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-9ecf431706524da7e45baec1936771de30c8e33dd846a59475a975a444665c883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2409608538&rft_id=info:pmid/32550263&rfr_iscdi=true